Form 4: Exelixis CSO Sells Shares in Recent Transaction

Dana Aftab, CSO of Exelixis, Inc., recently sold 20,883 shares of common stock at an average price of $27.06.

Summary

• Dana Aftab, the Chief Strategy Officer and Executive Vice President, Discovery & Translational Research at Exelixis, Inc., reported a transaction involving the company's common stock.
• On August 12, 2024, Aftab sold 20,883 shares of common stock at a weighted average price of $27.06.
• The sales occurred in multiple transactions with prices ranging from $27.05 to $27.09.
• Following the reported transaction, Aftab directly owns 500,107 shares of Exelixis, Inc.
• This includes 288,932 shares that will be issued upon vesting of restricted stock units (RSUs).
• Aftab also indirectly owns 5,835 shares through the Exelixis, Inc. 401(k) Plan as of August 11, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.

Stakeholder Impact

• The stock sale by a company officer may be of interest to shareholders, but the impact is likely minimal given the volume of shares traded relative to the company's overall market capitalization.

Key Dates